For years I had been having issues with getting viruses and trojans on my PC. I couldn’t figure out what the cause could be, until I talked to a friend who was an expert in the field. He told me to disable Java in my browser and I’d never have a problem again. Low and behold, I did as he said and I never experienced having to remove exploits and viruses from my computer again. Oracle Corporation (NYSE:ORCL) has finally decided to kill off the Java browser plugin, to the anger of some, but to the pleasure of those who realize that this has been the cause of many viruses over the years.
“Oracle plans to deprecate the Java browser plugin in JDK 9,” the Java Platform Group said on their blog. “This technology will be removed from the Oracle JDK and JRE in a future Java SE release.” Oracle does not plan to provide additional browser-specific plugins as such plugins would require application developers to write browser-specific applets for each browser they wish to support. Moreover, without a cross-browser API, Oracle would only be able to offer a subset of the required functionality, different from one browser to the next, impacting both application developers and users.”
This is a great move for Oracle Corporation (NYSE:ORCL) as the world of internet browsers become more acclimated with other sources of displaying media. The stock is up 0.93% or $0.33 following the news, hitting $35.24 per share. About 1.72 million shares traded hands. ORCL has declined 16.30% since June 23, 2015 and is downtrending. It has underperformed the S&P500 by 5.28%.
From a total of 17 analysts covering Oracle (NYSE:ORCL) stock, 11 rate it a “Buy”, 0 a “Sell”, and 6 a “Hold”. This means that 65% of the ratings are positive. The highest target price is $50 while the lowest target price is $41. The mean of all analyst targets is $44.67 which is 26.76% above today’s ($35.24) stock price. Oracle was the topic of 19 analyst reports since July 30, 2015 according to the firm StockzIntelligence Inc. BMO Capital Markets initiated shares on January 8 with a “Market Perform” rating. Goldman Sachs upgraded shares to a”Conviction Buy” rating and a $47 target share price in their report from a November 16. UBS maintained ORCL stock in a recent report from December 17 with a “Buy” rating. Morgan Stanley downgraded the rating on November 11. Morgan Stanley has a “Equal-Weight” rating and a $45 price target on shares. Finally, RBC Capital Markets maintained the stock with a “Outperform” rating in a report they issued on a December 17.
The institutional sentiment decreased to 0.72 in Q2 2015. It’s down 0.15, from 0.87 in 2015Q2. The ratio worsened, as 130 funds sold all their Oracle Corporation shares they owned while 622 reduced their positions. 67 funds bought stakes while 471 increased their total positions. Institutions now own 2.29 billion shares which is 9.81% less than the previous share count of 2.54 billion in 2015Q2.
Black Creek Investment Management Inc. holds 12.2% of its total portfolio in Oracle Corporation, equating to 2.57 million shares. Caledonia Investments Plc owns 862,500 shares representing 11.21% of their total US portfolio. Moreover, Mountain Lake Investment Management Llc has 9.09% of their total portfolio invested in the company, equating to 312,500 shares. The Alabama-based Vulcan Value Partners Llc has a total of 8.17% of their portfolio invested in the stock. Veritas Investment Management Llp, a United Kingdom-based fund reported 983,915 shares owned.
Oracle Corporation is a provider of enterprise software and computer hardware products, and services. The company has a market cap of $146.33 billion. The Company’s offerings include Oracle database and middleware software, application software, cloud infrastructure, hardware systems including computer server, storage and networking products, and related services. It has 16.96 P/E ratio.